biologics · biosimilars · specialty medicines
From first cell
to final vial.
Orvane develops, files and manufactures biosimilars and specialty medicines for partners in 62 markets. Four European sites, one quality system.
01 / 04 · development
Reference characterisation, cell line and process, analytical similarity.
scroll to turn the louvres · point to look ahead
Film: Mikhail Nilov, Pexels
( 01 ) who we are
We make complex medicines affordable, and we make them here, in Europe.
Biosimilars bring the same molecule to more patients once a patent expires. Building one takes eight years, a few hundred million euros and a quality system that never sleeps. That is the whole of our business: we do it for partners who sell in their own markets, under their own names.
- 2009founded in Ghent
- 4sites in four countries
- 9inspections, zero critical findings

Photo: Jess Loiterton, Pexels

Photo: RDNE Stock project, Pexels
“A biosimilar is a promise kept for ten years, batch after batch.”
mathis verhaegen · chief executive
Film: Usman AbdulrasheedGambo, Pexels
( 02 ) orvane in numbers, 2026
- 8,000litres
of single-use bioreactor capacity in Ghent
- 62markets
supplied through 14 commercial partners
- 11programmes
from preclinical to marketed
- 1,750people
scientists, engineers and operators
( 03 ) what we do
Three businesses, one plant logic.
- a
Biosimilars
Monoclonal antibodies and fusion proteins, developed from clone to dossier and supplied under our partners' names.
- b
Specialty medicines
Ready-to-use injectables and long-acting depots that remove a step on the ward.
- c
Partner manufacturing
Our spare drug-substance and fill-finish capacity, offered to other developers by the batch or by the year.

Photo: Tara Winstead, Pexels
Film: Usman AbdulrasheedGambo, Pexels

Photo: Thirdman, Pexels
( 04 ) four pillars
What a partner gets.
( 05 ) how it works
One programme, four stages, one team.
( 06 ) pipeline
Eleven programmes, in the open.
( 07 ) partners
Our medicines reach patients under fourteen partners' names.
( 08 ) leadership
The people who sign the release.
( 09 ) insights
Latest from Orvane.
Film: Bhavesh Mariyappa, Pexels
( 10 ) careers
Gown up. Sign off. Go home proud.
Operators, analysts, engineers and writers in Ghent, Leiden, Brno and Braga. Every new starter spends their first week on a filling line, whatever their job.
- 38open roles
- 31%of managers promoted from the floor
Film: Thilak S, Pexels
( 11 ) partnering
Bring us a molecule.
Or a market.
License a marketed product for your territory, co-develop a programme still open for partnering, or book drug-substance and fill-finish capacity by the batch.
( 12 ) contact